Charles River Labs (CRL) stock and LabCorp (LH) stock were upgraded and Quest Diagnostics (DGX) stock was downgraded at Citi.

Since a new CEO moved Surgical Solutions to Kansas City 17 months ago, the company has been making significant strides, ...

LH stays on investors' radar owing to its strong focus on high-growth areas and pursuing strategic acquisitions.

Shares of Labcorp Holdings Inc. LH rose 1.31% to $251.04 Friday, on what proved to be an all-around positive trading session ...

Labcorp has been a great trade, beating the S&P 500 by 6.9%. Its stock price has climbed to $255.01, representing a healthy ...

Fintel reports that on March 4, 2025, Citigroup upgraded their outlook for Labcorp Holdings (NYSE:LH) from Neutral to Buy.

A vehicle crashed into the LabCorp business at 595 Loudon Rd in Newton Plaza II on March 4, causing significant damage to the ...

Citi upgraded Labcorp (LH) to Buy from Neutral with a price target of $300, up from $250. Utilization rates have been running high ...

This was the stock's second consecutive day of losses.

A Wall Street analyst issued contrasting ratings on Tuesday for two major diagnostic testing companies, upgrading shares of ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the clinical availability of Labcorp® Plasma CompleteTM, a circulating tumor DNA (ctDNA)-based ...

According to Benzinga Pro, Labcorp Hldgs's peer group average for short interest as a percentage of float is 9.75%, which ...